Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2025-12-24 @ 11:45 PM
NCT ID:
NCT02866851
Eligibility Criteria:
Inclusion Criteria:
1. Patient with a histologically proven cancer regardless of the location (solid tumor or not) except brain tumor
2. Patient should receive chemotherapy (any indication) associated with overall risk of neutropenia greater than or equal to 20%
3. Age ≥ 18 years
4. Performance Status ≤ 3
5. Patient with Internet access and an email box
6. Patient affiliated to a social security scheme
7. Patient has given its written consent before any specific procedure for the study
Exclusion Criteria:
1. Symptomatic brain metastases
2. Persons deprived of liberty, under guardianship or under curators
3. dementia, mental impairment or psychiatric illness that may affect the patient's informed consent and / or protocol adherence and monitoring of the test
4. Patient unable to submit the protocol followed for psychological, social, family or geographical reasons
5. Pregnant or breastfeeding
6. Patients at risk of severe neutropenia (Absolute Neutrophils Count \<0.1 Giga / L within 7 days prior to inclusion, acute leukemia, auto or allograft)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02866851
Study Brief:
Protocol Section:
NCT02866851